# TAZORAC

NDC: 16110-916
Generic name: tazarotene
Labeler / Manufacturer: Almirall, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CREAM
Routes: CUTANEOUS
Marketing started: 20200203

FDA application: NDA021184

## Active ingredients

- TAZAROTENE: .1 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16110-916"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16110-916
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=021744d1-a6d7-4ad6-99c2-7187c24e64c6